Heathbridge Capital Management’s Pfizer PFE Stock Holding History

Heathbridge Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-19,183	Closed	-$584K	–	25
2014 Q1	$584K	Buy	19,183 +1,581	+9%	+$47.1K	0.16%	20
2013 Q4	$512K	Sell	17,602 -1,265	-7%	-$36.8K	0.15%	20
2013 Q3	$529K	Hold	18,867	–	–	0.16%	20
2013 Q2	$501K	Buy	+18,867	New	+$521K	0.18%	20

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Heathbridge Capital Management's PFE Position: Q2 2014 in Review

Heathbridge Capital Management sold out of Pfizer (PFE) in Q2 2014, closing a stake of 19,183 shares — an estimated $584K sold.

Heathbridge Capital Management first reported a position in PFE in Q2 2013 and held it in 4 quarters. The position peaked at $584K in Q1 2014. 1,747 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

Heathbridge Capital Management reported no remaining Pfizer position as of Q2 2014 after selling out during the quarter.
Heathbridge Capital Management sold 19,183 Pfizer shares in Q2 2014, an estimated $584K.
Heathbridge Capital Management first reported a position in Pfizer in Q2 2013 and held it in 4 quarters.
Heathbridge Capital Management's Pfizer position peaked at $584K in Q1 2014.
1,747 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Heathbridge Capital Management's 13F filing for Q2 2014, filed 29 Jul 2014.